[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:schizoaffective-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":310,"states":311},"Schizoaffective Disorder",80,62,[8,16,23,29,36,42,48,54,60,65,71,77,83,88,94,100,107,113,119,126,132,138,144,150,157,163,169,175,181,187,192,198,204,210,216,222,228,234,239,245,251,257,263,269,275,280,286,292,298,304],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04226898","Synbiotic Compound to Reduce Symptoms of Schizophrenia",[12],"Phase 2","RECRUITING","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:29.223305Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT03495024","Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates",[20],"Phase 4","2026-08-26T02:16:46.951087Z","2026-05-05T02:43:28.986001Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05208190","Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial",[20],"2026-08-26T02:19:01.741747Z","2026-05-05T02:43:28.845834Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT04887792","Acetazolamide for Treatment Resistant Schizophrenia",[33],"Phase 1\u002FPhase 2","2026-08-26T02:17:06.985283Z","2026-05-05T02:43:28.649805Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT04414215","Cognitive Training for Emotion Regulation in Psychotic Disorders",[],"2026-08-26T02:16:51.982021Z","2026-05-05T02:43:28.312470Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT05805397","Effectiveness of Motivation Skills Training (MST)",[],"2026-08-26T02:17:57.117858Z","2026-05-05T02:43:28.177877Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06174116","Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia",[20],"2026-08-26T02:18:14.396999Z","2026-05-05T02:43:28.162690Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT03794076","Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia",[33],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:27.848299Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":52,"content_modified":64},"NCT06221852","Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder",[],"2026-05-05T02:43:27.503882Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT07434479","A Virtual Reality Mindfulness Application for Aggression in Schizophrenia",[],"2026-08-26T02:16:15.345907Z","2026-05-05T02:43:27.423362Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT07469384","Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways",[],"2026-08-26T02:15:14.574786Z","2026-05-05T02:43:27.254226Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT05299749","Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations",[],"2026-08-26T02:15:54.846520Z","2026-05-05T02:35:31.600435Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":34,"content_modified":87},"NCT03971487","Ocrelizumab for Psychosis by Autoimmunity",[33],"2026-04-29T02:57:57.108870Z",{"nct_id":89,"title":90,"phases":91,"status":13,"updated_at":92,"content_modified":93},"NCT06562608","Anticholinergic Deprescription in Schizophrenia",[20],"2026-08-26T02:15:33.331531Z","2026-07-19T19:36:05.036281Z",{"nct_id":95,"title":96,"phases":97,"status":13,"updated_at":98,"content_modified":99},"NCT07098169","Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy",[],"2026-08-26T02:17:17.791881Z","2026-05-05T02:43:29.706351Z",{"nct_id":101,"title":102,"phases":103,"status":13,"updated_at":105,"content_modified":106},"NCT05025605","Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder",[104],"Phase 1","2026-08-26T02:17:16.126291Z","2026-05-05T02:43:29.678733Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT07196462","Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia",[],"2026-08-26T02:18:24.494016Z","2026-05-05T02:43:29.159669Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT06740890","Exercise and Olanzapine-samidorphan",[20],"2026-08-26T02:17:56.243868Z","2026-05-05T02:43:28.869711Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":124,"content_modified":125},"NCT06191965","MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction",[123],"Phase 2\u002FPhase 3","2026-08-26T02:15:10.362237Z","2026-05-05T02:43:28.851652Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT05064319","Gabapentin for Restoring GABA\u002FGlutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders",[12],"2026-08-03T03:09:02.952012Z","2026-05-05T02:43:28.537809Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT06969755","Biomarkers to Enhance Early Schizophrenia Treatment",[20],"2026-08-26T02:15:44.309045Z","2026-05-05T02:43:28.134812Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT07213466","Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder",[20],"2026-08-26T02:17:02.694423Z","2026-05-05T02:43:27.833235Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT04580134","CLOZAPINE Response in Biotype-1",[20],"2026-08-26T02:15:01.639696Z","2026-05-05T02:43:27.756557Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":155,"content_modified":156},"NCT06482554","Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.",[154],"Phase 3","2026-08-26T02:15:04.877798Z","2026-05-05T02:43:27.740656Z",{"nct_id":158,"title":159,"phases":160,"status":13,"updated_at":161,"content_modified":162},"NCT06118268","iTBS to Enhance Social Cognition in People With Psychosis",[],"2026-08-26T02:15:34.659160Z","2026-05-05T02:43:27.575263Z",{"nct_id":164,"title":165,"phases":166,"status":13,"updated_at":167,"content_modified":168},"NCT05890183","Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode",[],"2026-08-26T02:17:14.343713Z","2026-05-05T02:43:27.414334Z",{"nct_id":170,"title":171,"phases":172,"status":13,"updated_at":173,"content_modified":174},"NCT07006935","REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)",[],"2026-08-26T02:15:00.557154Z","2026-05-05T02:43:27.405115Z",{"nct_id":176,"title":177,"phases":178,"status":13,"updated_at":179,"content_modified":180},"NCT06529029","Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy",[123],"2026-08-26T02:17:32.059863Z","2026-05-05T02:43:27.307480Z",{"nct_id":182,"title":183,"phases":184,"status":13,"updated_at":185,"content_modified":186},"NCT06865937","Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)",[],"2026-08-26T02:17:43.321968Z","2026-05-05T02:43:27.244462Z",{"nct_id":188,"title":189,"phases":190,"status":13,"updated_at":92,"content_modified":191},"NCT04763655","Neural Biomarkers of Electroconvulsive Therapy Response",[],"2026-05-05T02:43:27.131038Z",{"nct_id":193,"title":194,"phases":195,"status":13,"updated_at":196,"content_modified":197},"NCT05157620","Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness",[],"2026-08-26T02:18:46.137046Z","2026-05-05T02:43:26.852438Z",{"nct_id":199,"title":200,"phases":201,"status":13,"updated_at":202,"content_modified":203},"NCT06071858","Enhanced Coordinated Specialty Care for Early Psychosis",[],"2026-08-26T02:17:26.640202Z","2026-04-29T02:57:57.116803Z",{"nct_id":205,"title":206,"phases":207,"status":13,"updated_at":208,"content_modified":209},"NCT05656469","Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders",[],"2026-08-26T02:15:25.633039Z","2026-07-05T05:32:16.807652Z",{"nct_id":211,"title":212,"phases":213,"status":13,"updated_at":214,"content_modified":215},"NCT06758414","CBT-CP for Veterans With SMI",[],"2026-08-26T02:15:58.452248Z","2026-05-05T02:43:28.487310Z",{"nct_id":217,"title":218,"phases":219,"status":13,"updated_at":220,"content_modified":221},"NCT06586164","Enhancing Rehabilitation for Veterans With Serious Mental Illness",[],"2026-08-26T02:18:52.966503Z","2026-05-05T02:43:28.214077Z",{"nct_id":223,"title":224,"phases":225,"status":13,"updated_at":226,"content_modified":227},"NCT05491538","Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness",[],"2026-08-26T02:16:03.788292Z","2026-05-05T02:43:27.290544Z",{"nct_id":229,"title":230,"phases":231,"status":13,"updated_at":232,"content_modified":233},"NCT07105111","A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor",[20],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:27.259690Z",{"nct_id":235,"title":236,"phases":237,"status":13,"updated_at":117,"content_modified":238},"NCT06898879","Enhancing Veteran-Clinical Collaboration in VA PRRCs",[],"2026-05-05T02:35:31.918194Z",{"nct_id":240,"title":241,"phases":242,"status":13,"updated_at":243,"content_modified":244},"NCT01409109","Database Registry for Neural Network Biomarkers in Psychosis",[],"2026-08-26T02:16:10.529598Z","2026-05-13T02:55:06.072517Z",{"nct_id":246,"title":247,"phases":248,"status":13,"updated_at":249,"content_modified":250},"NCT07703670","MicroRNAs as Biomarkers in First Episode Schizophrenia",[],"2026-08-26T02:16:20.336282Z","2026-07-19T19:36:05.088981Z",{"nct_id":252,"title":253,"phases":254,"status":13,"updated_at":255,"content_modified":256},"NCT07419321","Social Isolation and Aging in Schizophrenia",[],"2026-08-26T02:18:00.873391Z","2026-05-13T02:55:06.701981Z",{"nct_id":258,"title":259,"phases":260,"status":13,"updated_at":261,"content_modified":262},"NCT05945602","Neurophysiologic Biomarkers for Cognitive Rehabilitation",[],"2026-08-26T02:19:17.380174Z","2026-05-13T02:55:06.396368Z",{"nct_id":264,"title":265,"phases":266,"status":13,"updated_at":267,"content_modified":268},"NCT07713849","Transition Care for FEP",[],"2026-08-26T02:19:31.671303Z","2026-07-24T01:27:14.911884Z",{"nct_id":270,"title":271,"phases":272,"status":13,"updated_at":273,"content_modified":274},"NCT07263022","Cognitive Strategies in Early Psychosis 2",[154],"2026-08-26T02:18:59.761994Z","2026-07-24T01:27:14.903902Z",{"nct_id":276,"title":277,"phases":278,"status":13,"updated_at":185,"content_modified":279},"NCT06740383","Biomarkers\u002FBiotypes, Course of Early Psychosis and Specialty Services",[],"2026-05-13T02:55:06.569022Z",{"nct_id":281,"title":282,"phases":283,"status":13,"updated_at":284,"content_modified":285},"NCT05823532","Anti-Inflammatory Challenge in Schizophrenia",[20],"2026-08-26T02:16:50.548894Z","2026-06-16T05:54:07.912578Z",{"nct_id":287,"title":288,"phases":289,"status":13,"updated_at":290,"content_modified":291},"NCT05343598","Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia",[],"2026-08-26T02:18:29.369233Z","2026-05-05T02:43:29.495878Z",{"nct_id":293,"title":294,"phases":295,"status":13,"updated_at":296,"content_modified":297},"NCT02455193","Neuronal Effects of Exercise in Schizophrenia",[],"2026-08-26T02:15:56.561131Z","2026-05-05T02:43:28.312983Z",{"nct_id":299,"title":300,"phases":301,"status":13,"updated_at":302,"content_modified":303},"NCT06003036","Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine",[],"2026-08-03T02:37:16.921019Z","2026-05-05T02:43:28.296968Z",{"nct_id":305,"title":306,"phases":307,"status":13,"updated_at":308,"content_modified":309},"NCT06911931","Visual Perception in Schizophrenia",[],"2026-08-26T02:18:26.932189Z","2026-05-05T02:43:29.357637Z",[],[312,316,320,324,327,331,335,339,343,347,350,354,357],{"state":313,"count":314,"slug":315},"California",19,"california",{"state":317,"count":318,"slug":319},"New York",14,"new-york",{"state":321,"count":322,"slug":323},"Massachusetts",12,"massachusetts",{"state":325,"count":322,"slug":326},"Pennsylvania","pennsylvania",{"state":328,"count":329,"slug":330},"Texas",9,"texas",{"state":332,"count":333,"slug":334},"Georgia",7,"georgia",{"state":336,"count":337,"slug":338},"Maryland",6,"maryland",{"state":340,"count":341,"slug":342},"Connecticut",5,"connecticut",{"state":344,"count":345,"slug":346},"Illinois",4,"illinois",{"state":348,"count":345,"slug":349},"Tennessee","tennessee",{"state":351,"count":352,"slug":353},"Alabama",3,"alabama",{"state":355,"count":352,"slug":356},"Florida","florida",{"state":358,"count":352,"slug":359},"Minnesota","minnesota"]